✦ LIBER ✦

A risk-benefit analysis of pioglitazone

✍ Scribed by Nali, Luiz HS; Olival, Guilherme S; de Oliveira, Augusto CP; Casseb, Jorge; Vidal, Jose E; Moraes, Lenira; Fink, Maria CD; Sumita, Laura M; Romano, Camila M

Book ID: 121575092
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2014
Weight: 199 KB
Volume: 1483
Category: Article
ISSN: 0114-9954
DOI: 10.1007/s40278-014-7827-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit-Risk Analysis

✍ Dr William L. Holden 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 248 KB

Risk-Benefit Analysis

✍ Haigh, John 📂 Article 📅 2003 🏛 American Statistical Association 🌐 English ⚖ 84 KB

A risk–benefit analysis of vaccination

✍ Ulrich Heininger 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 252 KB

The risks! and benefits? of risk-benefit

The risks! and benefits? of risk-benefit analysis

✍ Stuart E Dreyfus 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 535 KB

Risk–benefit analysis of micronutrients

✍ A.G. Renwick; A. Flynn; R.J. Fletcher; D.J.G. Müller; S. Tuijtelaars; H. Verhage 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 544 KB

Prostate Biopsy: A Risk-Benefit Analysis

✍ Loeb, Stacy 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 102 KB